Splice site mutations in a xeroderma pigmentosum group A patient with delayed onset of neurological disease

Mutation Research - DNA Repair

Volumn 363, Issue 3, 1996, Pages 171-177

  States, J Christopher ^a   Myrand, Scott P ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Delayed onset neurological disease; Splice site muation; Xeroderma pigmentosum

Indexed keywords

ARTICLE; FIBROBLAST; HUMAN; HUMAN CELL; MUTATION; NEUROLOGIC DISEASE; PRIORITY JOURNAL; XERODERMA PIGMENTOSUM;

EID: 0030575545     PISSN: 09218777     EISSN: None     Source Type: Journal    
DOI: 10.1016/0921-8777(96)00004-3     Document Type: Article

References (16)

1. Andrews, A.D., S.F. Barrett and J.H. Robbins (1978) Xeroderma pigmentosum neurological abnormalities correlate with colony-forming ability after ultraviolet radiation. Proc. Natl. Acad. Sci. USA. 75, 1984-1988.
2. Cleaver, J.E., W.C. Charles, G.H. Thomas and M.L. McDowell (1995) A deletion and an insertion in the alleles for the xeroderma pigmentosum (XPA) DNA-binding protein in mildly affected patients. Hum. Mol. Genet., 4, 1685-1687.
3. Fan, E., D.B. Levin, B.W. Glickman and D.M. Logan (1993) Limitations in the use of SSCP analysis. Mutation Res., 288, 85-92.
4. Friedberg, E.C., G.C. Walker and W. Siede (1995) DNA Repair and Mutagenesis, ASM Press, Washington, DC.
5. Grompe, M. (1993) The rapid detection of unknown mutations in nucleic acids. Nature Genet., 5, 111-117.
6. Jones, C.J., R.S. Lloyd and R.D. Wood (1994) Analysis of cells harboring a putative DNA repair gene reveals a lack of evidence for a second independent xeroderma pigmentosum group A correcting gene. Mutation Res., 324, 159-164.
7. Kantor, G.J. and D.R. Hull (1984) The rate of removal of pyrimidine dimers in quiescent cultures of normal human and xeroderma pigmentosum cells, Mutation Res., 132, 21-31.
8. Kaur, G.P., A. Rinaldy, R.S. Lloyd and R.S. Athwal (1992) A gene that partially complements xeroderma pigmentosum group A cells maps to human chromosome 8, Somat. Cell Mol. Genet., 18, 371-379.
9. Kawasaki, E.S. and A.M. Wang (1989) Detection of gene expression, in: H.A. Erlich (Ed.), PCR Technology: Principles and Applications for DNA Amplification, Stockton Press, New York, pp. 89-97.
10. Rinaldy, A., T. Bellew, E. Egli and R.S. Lloyd (1990) Increased UV resistance in xeroderma pigmentosum group A cells after transformation with a human genetic DNA clone, Proc. Natl. Acad. Sci. USA, 87, 6818-6822.
11. Robbins, J.H., R.A. Brumback, M. Mendiones, S.F. Barrett, J.R. Carl, S. Cho, M.B. Denckla, M.B. Ganges, L.H. Gerber, R.A. Guthrie et al. (1991) Neurological disease in xeroderma pigmentosum. Documentation of a late onset type of the juvenile onset form, Brain, 114, 1335-1361.
12. Satokata, I., K. Tanaka, N. Miura, I. Miyamoto, Y. Satoh, S. Kondo and Y. Okada (1990) Characterization of a splicing mutation in group A xeroderma pigmentosum, Proc. Natl. Acad. Sci. USA, 87, 9908-9912.
13. Satokata, I., K. Tanaka, S. Yuba and Y. Okada (1992) Identification of splicing mutations of the last nucleotides of exons, a nonsense mutation, and a missense mutation of the XPAC gene as causes of group A xeroderma pigmentosum, Mutation Res., 273, 203-212.
14. Satokata, I., M. Uchiyama and K. Tanaka (1995) Two novel splicing mutations in the XPA gene in patients with group A xeroderma pigmentosum, Hum. Mol. Genet., 4, 1993-1994.
15. Shimamoto, T., K. Kohno, K. Tanaka and Y. Okada (1991) Molecular cloning of human XPAC gene homologs from chicken. Xenopus laeris and Drosophila melanogaster, Biochem. Biophys. Res. Commun., 181, 1231-1237.
16. Vancutsem, P.M., P. Lazarus and G.M. Williams (1994) Frequent and specific mutations of the rat p53 gene in hepatocarcinomas induced by tamoxifen. Cancer Res., 54, 3864-3867.